Validation of claims-based algorithms for gout flares

Purpose Gout is a common inflammatory arthritis characterized by repeated acute flares. The ability to accurately identify gout flares is critical for comparative effectiveness studies of gout treatments. We developed and examined the accuracy of a claims‐based algorithm to identify gout flares. Met...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Pharmacoepidemiology and drug safety Ročník 25; číslo 7; s. 820 - 826
Hlavní autori: MacFarlane, Lindsey A., Liu, Chih-Chin, Solomon, Daniel H., Kim, Seoyoung C.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England Blackwell Publishing Ltd 01.07.2016
Wiley Subscription Services, Inc
Predmet:
ISSN:1053-8569, 1099-1557, 1099-1557
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Purpose Gout is a common inflammatory arthritis characterized by repeated acute flares. The ability to accurately identify gout flares is critical for comparative effectiveness studies of gout treatments. We developed and examined the accuracy of a claims‐based algorithm to identify gout flares. Methods Patients receiving care at an academic medical center between 2006 and 2010 with a diagnosis of gout or hyperuricemia were selected using an electronic medical record‐Medicare claims linked dataset. Gout flares were identified by several claims‐based algorithms using a diagnosis of gout combined with gout‐related medication claims and/or procedure codes for arthrocentesis or joint injection. We calculated positive predictive value of these algorithms based on physician documentation of gout flare in medical record as the gold standard. Negative predictive value of the gout flare algorithm was calculated in a randomly selected subgroup of 200 patients with gout. Results Among 3952 subjects with gout or hyperuricemia, 503 flares were identified using the medication‐based algorithm, and 290 were identified using the procedure‐based algorithm. The positive predictive value for gout flares ranged from 50–54% for the medication‐based algorithms and 59–68% for the procedure‐based algorithms. The negative predictive value of the algorithm combining both medication and procedure claims was high (85.2%). Conclusion Use of gout diagnosis codes in combination with medication dispensing or procedure codes did not appear to accurately capture gout flares in patients with gout in a claims database. However, the claims‐based flare algorithm could be useful in identifying a cohort of gout patients with no flares. Copyright © 2016 John Wiley & Sons, Ltd.
Bibliografia:ark:/67375/WNG-30J5QPC0-4
ArticleID:PDS4044
NIH - No. K24 AR055989
istex:7BD68D88929CA84214C54393682CBC8765CD8C19
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
ISSN:1053-8569
1099-1557
1099-1557
DOI:10.1002/pds.4044